No abstract available
Keywords:
chronic myeloid leukemia; phase II; ponatinib; resistant; tyrosine kinase inhibitor.
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adult
-
Aged
-
Drug Resistance, Neoplasm / drug effects*
-
Female
-
Humans
-
Imidazoles / administration & dosage*
-
Imidazoles / adverse effects
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / enzymology
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
-
Male
-
Middle Aged
-
Protein Kinase Inhibitors / administration & dosage*
-
Protein Kinase Inhibitors / adverse effects
-
Pyridazines / administration & dosage*
-
Pyridazines / adverse effects
Substances
-
Imidazoles
-
Protein Kinase Inhibitors
-
Pyridazines
-
ponatinib